Sign inGet started

Farag Kameel D.

Insider CIK 2093620 · AKTX Interim CFO · BIVI Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AKTX Akari Therapeutics Plc A Award2026-08-172026-08-191,728$7.52 $13.0K23,309SEC↗
AKTX Akari Therapeutics Plc A Award2026-08-172026-08-191,728$7.52 $13.0K23,309SEC↗
AKTX Akari Therapeutics Plc A Award2026-07-162026-08-051,130$11.50 $13.0K21,581SEC↗
AKTX Akari Therapeutics Plc A Award2026-07-162026-08-051,130$11.50 $13.0K21,581SEC↗
AKTX Akari Therapeutics Plc A Award2026-06-242026-06-251,248$10.02 $12.5K2,870SEC↗
AKTX Akari Therapeutics Plc A Award2026-06-242026-06-251,395$9.32 $13.0K4,265SEC↗
AKTX Akari Therapeutics Plc A Award2026-06-242026-06-253,725$3.49 $13.0K12,099SEC↗
AKTX Akari Therapeutics Plc A Award2026-06-242026-06-252,539$5.12 $13.0K8,374SEC↗
AKTX Akari Therapeutics Plc A Award2026-06-242026-06-251,000$13.00 $13.0K20,452SEC↗
AKTX Akari Therapeutics Plc A Award2026-06-242026-06-257,353$3.74 $27.5K19,452SEC↗
AKTX Akari Therapeutics Plc A Award2026-06-242026-06-251,570$8.28 $13.0K5,835SEC↗
BIVI BIOVIE INC. A Award deriv2026-01-052026-01-0957,500— $057,500SEC↗
AKTX Akari Therapeutics Plc P Buy deriv2025-12-162025-12-1824,745— $024,745SEC↗
AKTX Akari Therapeutics Plc P Buy deriv2025-12-162025-12-1824,745$0.40 $9.9K24,745SEC↗
AKTX Akari Therapeutics Plc A Award2025-11-012025-11-0432,000$0.75 $24.0K32,000SEC↗
AKTX Akari Therapeutics Plc A Award2025-11-012025-11-0426,619$0.75 $20.0K26,619SEC↗
AKTX Akari Therapeutics Plc A Award2025-10-222025-10-246,277$0.74 $4.6K6,277SEC↗